GlobalGov › Germany › Solicitation

Germany – Pharmaceutical products – Open-House-Rabattverträge 2026-15

Techniker Krankenkasse · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

October 31, 2028
Response Due
Active
Status

Opportunity Overview

Die Krankenkassen verfolgen das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V über die im jeweiligen Los genannten Wirkstoffe, Wirkstoffkombinationen bzw. Darreichungsformen, Wirkstärken oder Fertigarzneimittel zu schließen. Folgende Wirkstoffe, Wirkstoffkombinationen bzw. Darreichungsformen, Wirkstärken oder Fertigarzneimittel sind Bestandteil des vorliegenden Verfahrens (zu den Einzelheiten siehe Angaben bei den jeweiligen Losentitel): Aripiprazol (parenterale Depot-Darreichungsformen, ausgenommen N3) Atropinsulfat (ATR) Colistimethat natrium (ausgenommen HPI, IKA) Fenoterol/Ipratropium bromid (DOS) Glyceroltrinitrat (SAL) Guanfacin (Wirkstärken: 1-4 mg) Levonorgestrel (IUP) Menotropin (PEN) Menotropin (PLI) Perindopril/Amlodipin Pitolisant (Ind.: Narkolepsie, 4,45 mg) Pitolisant (Ind.: Narkolepsie, 17,81 mg) Quetiapin (RET: N1, ausgenommen 50 mg und 600 mg) Zolmitriptan (nasale DRF)

This Germany Health Services opportunity is one most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyTechniker Krankenkasse
CountryGermany
CategoryHealth Services
PublishedSeptember 22, 2026
Procurement stageRequest for Proposal (RFP)
Response dueOctober 31, 2028
StatusOpen — accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedOctober 07, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Browse all categories →

Related Opportunities in Germany

Germany – IT services: consulting, software development, Internet and support – TK-Schwangerschaftsapp
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-02 - Rituximab (Darreichungsform zur subkutanen Injektion)
Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-16
Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-06
Germany – Pharmaceutical products – Open-House-Originale-Rabattverträge 2024-14 - Bimatoprost / Timolol (Darreichungsform: Augentropfen als Einzeldosispipetten)
Germany – Purchase of CO2 emission credits – Erwerb und Stilllegung von CO2-Emissionsgutschriften II
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-12 - Glycopyrroniumbromid (Darreichungsform: Hartkapseln mit Pulver zur Inhalation)
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-33 - Propranolol (Darreichungsform: Lösung zum Einnehmen)

See every Germany Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Health Services intelligence report in your inbox

A personalized report on Germany Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.